Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;477(3):467-468.
doi: 10.1007/s00428-020-02896-4.

Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor

Sigurd F Lax  1   2 , Kristijan Skok  3 , Michael Trauner  4 ; all coauthors
Affiliations
Comment

Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor

Sigurd F Lax et al. Virchows Arch. 2020 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Skok declares no conflict of interest. Dr. Lax reports personal fees from Roche, AstraZeneca, Novartis, and Biogena outside the submitted work. Dr. Trauner has received speaker fees from Bristol-Myers Squibb, Falk, Gilead, Intercept and Merck Sharp & Dohme (MSD); advisory board fees from Albireo, Boehringer Ingelheim, BiomX, Falk, Genfit, Gilead, Intercept, MSD, Novartis, Phenex, and Regulus; travel grants from AbbVie, Falk, Gilead, and Intercept; and research grants from Albireo, CymaBay, Falk, Gilead, Intercept, MSD, and Takeda all outside the submitted work.

Comment on

References

    1. Bosmuller H, Traxler S, Bitzer M, Haberle H, Raiser W, Nann D, Frauenfeld L, Vogelsberg A, Klingel K, Fend F (2020) The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation. Virchows Arch. 10.1007/s00428-020-02881-x - PMC - PubMed
    1. Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, Vander K, Bargfrieder U, Trauner M (2020) Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center. Ann Intern Med. 10.7326/M20-2566 - PMC - PubMed
    1. Greene R, Lind S, Jantsch H, Wilson R, Lynch K, Jones R, Carvalho A, Reid L, Waltman AC, Zapol W. Pulmonary vascular obstruction in severe ARDS: angiographic alterations after I.V. fibrinolytic therapy. AJR Am J Roentgenol. 1987;148(3):501–508. doi: 10.2214/ajr.148.3.501. - DOI - PubMed
    1. Cattaneo M, Bertinato EM, Birocchi S, Brizio C, Malavolta D, Manzoni M, Muscarella G, Orlandi M (2020) Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?. Thromb Haemost. 10.1055/s-0040-1712097 - PMC - PubMed
    1. Deshpande C (2020) Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism?. Ann Intern Med. 10.7326/M20-3255 - PMC - PubMed